Literature DB >> 23364589

Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.

Christopher P Larsen, Patrick D Walker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364589     DOI: 10.1038/ki.2012.385

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  6 in total

1.  C4d as a Diagnostic Tool in Proliferative GN.

Authors:  Sanjeev Sethi; Samih H Nasr; An S De Vriese; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-05-19       Impact factor: 10.121

2.  An Interdisciplinary Diagnostic Approach to Guide Therapy in C3 Glomerulopathy.

Authors:  Tilman Schmidt; Sara Afonso; Luce Perie; Karin Heidenreich; Sonia Wulf; Christian F Krebs; Peter F Zipfel; Thorsten Wiech
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.

Authors:  Aishwarya Ravindran; Fernando C Fervenza; Richard J H Smith; Sanjeev Sethi
Journal:  Kidney Int       Date:  2018-05-03       Impact factor: 10.612

4.  C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.

Authors:  Aishwarya Ravindran; Fernando C Fervenza; Richard J H Smith; An S De Vriese; Sanjeev Sethi
Journal:  Mayo Clin Proc       Date:  2018-08       Impact factor: 7.616

5.  Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy.

Authors:  Eric Kerns; David Rozansky; Megan L Troxell
Journal:  Pediatr Nephrol       Date:  2013-07-28       Impact factor: 3.714

6.  C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy.

Authors:  Shaarif Bashir; Mudassar Hussain; Aurangzeb Afzal; Usman Hassan; Maryam Hameed; Sajid Mushtaq
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.